135 related articles for article (PubMed ID: 23258648)
21. Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout.
Moriwaki Y; Yamamoto T; Takahashi S; Yamakita J; Tsutsumi Z; Hada T
J Rheumatol; 2001 Jun; 28(6):1306-10. PubMed ID: 11409124
[TBL] [Abstract][Full Text] [Related]
22. The diverse associations of uric acid with low-grade inflammation, adiponectin and arterial stiffness in never-treated hypertensives.
Tsioufis C; Kyvelou S; Dimitriadis K; Syrseloudis D; Sideris S; Skiadas I; Katsi V; Stefanadi E; Lalos S; Mihas C; Poulakis M; Stefanadis C
J Hum Hypertens; 2011 Sep; 25(9):554-9. PubMed ID: 20962858
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of health care costs and utilization patterns for patients with gout.
Park H; Rascati KL; Prasla K; McBayne T
Clin Ther; 2012 Mar; 34(3):640-52. PubMed ID: 22381710
[TBL] [Abstract][Full Text] [Related]
24. Changes of serum uric acid level during acute gout flare and related factors.
Zhang J; Sun W; Gao F; Lu J; Li K; Xu Y; Li Y; Li C; Chen Y
Front Endocrinol (Lausanne); 2023; 14():1077059. PubMed ID: 36896178
[TBL] [Abstract][Full Text] [Related]
25. Acute gout attack with normal serum uric acid levels.
Bădulescu M; Macovei L; Rezuş E
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):942-5. PubMed ID: 25581951
[TBL] [Abstract][Full Text] [Related]
26. Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis.
Lu J; Bai Z; Chen Y; Li Y; Tang M; Wang N; Zhu X; Dai H; Zhang W
Rheumatology (Oxford); 2021 Aug; 60(8):3628-3634. PubMed ID: 33394025
[TBL] [Abstract][Full Text] [Related]
27. Hyperuricaemia: more than just a cause of gout?
Katsiki N; Karagiannis A; Athyros VG; Mikhailidis DP
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):397-402. PubMed ID: 23032963
[TBL] [Abstract][Full Text] [Related]
28. Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis.
Panoulas VF; Douglas KM; Milionis HJ; Nightingale P; Kita MD; Klocke R; Metsios GS; Stavropoulos-Kalinoglou A; Elisaf MS; Kitas GD
J Hum Hypertens; 2008 Mar; 22(3):177-82. PubMed ID: 17960169
[TBL] [Abstract][Full Text] [Related]
29. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
Dalbeth N; Kumar S; Stamp L; Gow P
J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
[TBL] [Abstract][Full Text] [Related]
30. Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors.
Goldfarb DS; MacDonald PA; Hunt B; Gunawardhana L
J Rheumatol; 2011 Jul; 38(7):1385-9. PubMed ID: 21572152
[TBL] [Abstract][Full Text] [Related]
31. Uric acid is associated with microalbuminuria and decreased glomerular filtration rate in the general population during 7 and 13 years of follow-up: The Tromsø Study.
Storhaug HM; Toft I; Norvik JV; Jenssen T; Eriksen BO; Melsom T; Løchen ML; Solbu MD
BMC Nephrol; 2015 Dec; 16():210. PubMed ID: 26651613
[TBL] [Abstract][Full Text] [Related]
32. Multicenter, open-label study of long-term administration of febuxostat (TMX-67) in Japanese patients with hyperuricemia including gout.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S50-6. PubMed ID: 21654270
[TBL] [Abstract][Full Text] [Related]
33. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
[TBL] [Abstract][Full Text] [Related]
34. Uric acid metabolism in patients with primary gout and the metabolic syndrome.
Fraile JM; Puig JG; Torres RJ; de Miguel E; Martínez P; Vázquez JJ
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):330-4. PubMed ID: 20544516
[TBL] [Abstract][Full Text] [Related]
35. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Palo WA; Eustace D; Vernillet L; Joseph-Ridge N
Arthritis Rheum; 2005 Mar; 52(3):916-23. PubMed ID: 15751090
[TBL] [Abstract][Full Text] [Related]
36. Benefits of uric acid-lowering medication after bariatric surgery in patients with gout.
Song K; He M; Kong X; Xian Y; Zhang Y; Xie X; Xie S; Jia A; Ren Y
BMC Surg; 2024 Jun; 24(1):186. PubMed ID: 38877436
[TBL] [Abstract][Full Text] [Related]
37. Incremental effects of serum uric acid levels, autonomic dysfunction, and low-grade inflammation on nocturnal blood pressure in untreated hypertensive patients and normotensive individuals.
Erden M; Kocaman SA; Poyraz F; Topal S; Sahinarslan A; Boyacı B; Cengel A; Yalçın MR
Turk Kardiyol Dern Ars; 2011 Oct; 39(7):531-9. PubMed ID: 21983762
[TBL] [Abstract][Full Text] [Related]
38. Microalbuminuria and uric acid in healthy subjects.
Bellomo G; Berardi P; Saronio P; Verdura C; Esposito A; Laureti A; Venanzi S; Timio F; Timio M
J Nephrol; 2006; 19(4):458-64. PubMed ID: 17048203
[TBL] [Abstract][Full Text] [Related]
39. The association of serum C-reactive protein, uric acid and magnesium with insulin resistance in Chinese postmenopausal women with prediabetes or early untreated diabetes.
Liu ZM; Ho SC
Maturitas; 2011 Oct; 70(2):176-81. PubMed ID: 21821372
[TBL] [Abstract][Full Text] [Related]
40. Cross-sectional association of serum C-reactive protein and uric acid with albuminuria in Chinese type 2 diabetic patients.
Ling Y; Li XM; Gao X
Chin Med J (Engl); 2013 Nov; 126(21):4023-9. PubMed ID: 24229668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
